Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
boston
europe blog main
europe top stories
indiana blog main
indiana top stories
roche
san francisco blog main
san francisco top stories
aimmune therapeutics
allergy
anaphylaxis
andrew oxtoby
avapritinib
biopharma
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
capmatinib
clinical trials
daniel edelman
deals
detroit blog main
detroit top stories
duchenne
eli lilly
eosinophilic esophagitis
fda
food allergy
gastrointestinal stromal tumors
genentech
immunotherapy
jayson dallas
What
approval
3
×
fda
3
×
therapy
3
×
drug
therapeutics
won
address
agency
aimmune
allergy
approved
approves
awarded
betting
billion
biopharma
blueprint
cancer
carries
certain
deal
designed
developed
duchenne
friday
gene
genetic
historic
immunotherapy
late
latest
medicine
medicines
oral
pass
peanut
puts
recently
ret
rna
Language
unset
Current search:
approval
×
" national top stories "
×
fda
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal